TY  - JOUR
T1  - THe pharmacist's role in off-label prescribing—reply
AU  - Largent EA, Miller FG, Pearson SD
Y1  - 2010/04/12
N1  - 10.1001/archinternmed.2010.71
JO  - Archives of Internal Medicine
SP  - 658
EP  - 658
VL  - 170
IS  - 7
N2  - 
In his letter, Dr Rupp raised a salient point regarding the difficulties posed to pharmacists by off-label prescribing and the relevant regulations. Clearly, off-label prescribing is an issue confronted not merely by patients and physicians. Fortunately, these additional stakeholders might also make unique contributions in addressing our concerns about evidence-based medicine, evidence development, patient notification, and health care costs. Dr Rupp's discussion of e-prescribing provides one example of this. We caution that any workable system should not interfere with patients receiving medications promptly or place an undue administrative burden on clinicians and pharmacists.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.71
UR  - http://dx.doi.org/10.1001/archinternmed.2010.71
ER  -